-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs017020-singh-final-report-2010.pdf
January 01, 2010 - Statin
SITE Total Patients Pts.
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015413-samore-final-report-2008.pdf
January 01, 2008 - A total of 148 coumadin-associated potential drug-drug
interactions (DDI), 43 statin-associated DDI … # of DDI per 100 person
months:
Range across clinics
Coumadin DDI 5.5 2.3-20.0 16.3 8.7-29.5
Statin … clinics
post-CCOE
# of DDI per 100 person
months:
Range
Coumadin DDI 9.9 5.1-26.5 12.9 1.7-18.6
Statin … combined: Rate
ratio calculated as post CCOE/pre CCOE:
Range rate ratio
Coumadin DDI 1.1 0.4-11.7
Statin
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-evaluation-summary-report-p233201500023I.pdf
March 23, 2022 - Performance
Partnering
Organization/
Implementation
Sites Artifact Name(s)
CDS Connect Pilots
Statin … Use for the Primary
Prevention of CVD artifact
MITRE March -
September
2017
AllianceChicago Statin … Part One,
Screening
Abnormal Blood Glucose
and Type 2 Diabetes
Mellitus: Part Two,
Counseling
Statin … Model Longitudinal
ASCVD Risk Assessment
Tool for Baseline 10-Year
ASCVD Risk (which was
within the Statin … https://cds.ahrq.gov/cdsconnect/artifact/statin-use-primary-prevention-cvd-adults-clinician-facing-cds-intervention
-
digital.ahrq.gov/2019-year-review/research-spotlights/improving-care-advancing-evidence-practice-through-interoperable
January 01, 2019 - healthy-diet-and-physical-activity-cvd-prevention-adults-cardiovascular-risk
3 https://cds.ahrq.gov/cdsconnect/artifact/statin-use-primary-prevention-cvd-adults-patient-facing-cds-intervention
-
digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
October 01, 2011 - of annual lab monitoring for all medication groups
(ACE-I/ARB, Digoxin, Diuretic, Anticonvulsant, Statin … , Fibrate, Glitazone, Nefazadone, Niacin
• High CK (>500)—Statin, Fibrate
• High TSH (>6)—Levothyroxine … of annual lab monitoring for all medication groups (ACE-I/ARB, Digoxin, Diuretic,
Anticonvulsant, Statin … Potassium high, on ACE-I/ARB 31 1179 2.6%
Creatinine high, on Metformin 16 548 2.9%
CK high, on Statin … or Fibrate 7 1212 0.6%
SGPT high, on Statin, Fibrate, Glitazone,
Nefazadone, or Niacin
4 1254 0.3%
-
digital.ahrq.gov/sites/default/files/docs/cds-authoring-tool-qas-020719.pdf
December 08, 2017 - For an example, see the alternate statin use configuration. … https://cds-hooks.org/
https://github.com/AHRQ-CDS/AHRQ-CDS-Connect-CQL-SERVICES/blob/master/localHooks/statin-use.json.alternate
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
January 01, 2017 - more than half of the alerts that would
have been triggered for DDIs involving cholesterol-lowering statin … drugs were inappropriate because the dose
of the statin was not considered by the software.24 More … Successful strategy to improve the specificity of electronic
statin-drug interaction alerts.
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs019726-kahn-final-report-2014.pdf
January 01, 2014 - 39400065 sertraline 58160070
Simvastatin 39400075
SNRI 5818 duloxetine 58180025
Combination,Products,(statin
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs022728-zhou-final-report-2018.pdf
January 01, 2018 - Encoding and Processing Patient Allergy Information in EHRs - Final Report
AHRQ Grant Final Progress Report
Title of Project:
Encoding and Processing Patient Allergy Information in EHRs
Principle Inve…
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs025005-snyder-final-report-2019.pdf
January 01, 2019 - Targeted by Alert (number of alerts evaluated)
Indication 5 Need for ACE/ARBb therapy (2)
Need for statin … 5 Drug-drug interaction to reduce plasma concentration of
immunosuppressant drug (1)
Sub-optimal statin … anti-diabetic) non-adherence (6)
Cost 2 Cost-savings opportunity through switch to alternative drug (statin
-
digital.ahrq.gov/sites/default/files/docs/citation/EnhancedMedHistoriesImplementationGuide.pdf
November 01, 2011 - for liver enzyme elevation)
• NSAID (Nonsteroidal Anti-inflammatory Drug)
• Potassium Supplement
• Statin … < 0.3
TSH > 6
K Supplement Potassium > 5.5
Metformin Creatinine > 1.4
NSAID Creatinine > 2.0
Statin … Levothyroxine TSH: none found in past 12 months
Anticonvulsant Serum drug level: none found in past 12 months
Statin
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017037-ornstein-final-report-2010.pdf
January 01, 2010 - • Avoidance of itraconazole and statin.
6
• Avoidance of lithium and thiazide.
-
digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-transcript-081811.pdf
June 16, 2021 - So if you have diabetes, often patients
would be on a statin, ACE-inhibitor-ARB, Solfunylurea, metformin … re on a drug or
if you weren’t because we wanted patients to - so maybe they stopped taking their statin … We wanted to give them a
different message than if they were taking their statin.
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs021581-goodney-final-report-2015.pdf
January 01, 2015 - congestive heart
failure, COPD, smoking, renal failure, contralateral carotid stenosis, and absence of statin
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017018-lehmann-final-report-2010.pdf
January 01, 2010 - Medication Monitoring for Vulnerable Populations via IT
Grant Final Report
Grant ID: R18HS17018-02
Medication Monitoring for Vulnerable
Populations via IT
Inclusive Dates: 09/21/07 – 05/31/10
Principal Investigator:
Dr. Christoph Ulrich Lehmann
Team Members:
Sean Berenholtz *
David …
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018226-sequist-final-report-2013.pdf
January 01, 2013 - A Risk-Based Approach to Improving Management of Chronic Kidney Disease - Final Report
Grant Final Report
Grant ID: R18HS018226
A Risk-Based Approach to Improving Management
of Chronic Kidney Disease
Inclusive Project Dates: 09/30/09 – 07/31/13
Principal Investigator:
Thomas D. Sequist MD, MPH
Team Membe…
-
digital.ahrq.gov/sites/default/files/docs/resource/B7_Archives_Pohl_HS17034_1013_1.pdf
February 14, 2011 - Data Analysis Protocol (Preliminary Draft)
1
“A Partnership for Clinician EHR Use & Quality of Care”
DATA ANALYSIS PROTOCOL
Revision Date: February 14, 2011
DATA COLLECTED
Note: All data are collected at the clinician level unless noted otherwise.
I. Medication Safety
A. Timepoints & Loo…
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017072-lobach-final-report-2011.pdf
January 01, 2011 - rules and the requirement to activate the rules
Medication Class Conditions Contributing to Rule
Statin … %
Arm #3
(Reports+)
Adherence
N=736
p
All Medication
Classes
41.3 41.2 0.82 42.9 0.35
Statin … %
Arm #3
(Reports+)
Adherence
N=493
p
All Medication
Classes
50.5 51.3 0.61 52.7 0.35
Statin
-
digital.ahrq.gov/sites/default/files/docs/clinical-care-slides-10142020.pdf
October 14, 2020 - A National Web Conference on Applying Advanced Analytics in Clinical Care: Slides
AHRQ National Web Conference on
Applying Advanced Analytics in Clinical Care
Moderated by:
Chun-Ju (Janey) Hsiao, PhD
Agency for Healthcare Research and Quality
Presented by:
Alexander Turchin, MD, MS
Judit…
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026257-friedman-final-report-2020.pdf
January 01, 2020 - cancer screening; Osteoporosis screening (if high risk), Sexually transmitted infections
counseling; Statin … activity counseling
HIV HIV Screening
OST Osteoporosis screening
LUN Lung cancer screening
STA Statin